"van Soest's ability to understand customer's needs in the proteomics arena has allowed Eksigent to continue our leadership in the drug discovery and biomarker sector with the NanoLC product line," commented Bill Masuda, CEO for Eksigent. "We will now leverage his exceptional product vision to our entire product line. His close relationships with industry-leading researchers will allow Eksigent to continue to provide users with leading-edge technology."
Prior to joining Eksigent, van Soest had specialized in the development and application of nano HPLC instrumentation for more than 15 years. He holds a Master of Science in Analytical Chemistry from Vrije Universiteit, in The Netherlands.
Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low-flow fluid delivery solutions. From precise separation of precious samples in proteomics research to fast and efficient analytical chromatography to unique medical devices that improve the way drugs are delivered, Eksigent brings novel solutions to customer challenges. The company combines proprietary microfluidic pumping technology with creative approaches that help customers improve productivity and expand their research and market opportunities. Eksigent serves customers throughout the world, including Europe, Asia and Australia, through a growing sales and service network. For more information, visit www.eksigent.com.
